OCT6 overexpression in parental lung adenocarcinoma cell lines resulted in an intracellular increase in oxaliplatin concentration, indicating that OCT6 mediates platinum drug entry in cancer cells and confers resistance to them when its expression is curtailed [61]. The gene discussed is SLC22A16; the disease is cancer.